Dustin Ziebarth, DO
Family Medicine · Twin Falls, IDNPI 1750644456
Payments from drug & device makers
Across 98 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$626
- Otsuka America Pharmaceutical, Inc.$131
- Novo Nordisk$107
- Corcept Therapeutics$82
- Pfizer$73
- Lilly USA, LLC$65
- plus $644 from 20 others
What the payments were for
- Food & beverage$1,70198%
- Other$292%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $626 |
| Otsuka America Pharmaceutical, Inc. | 7 | $131 |
| Novo Nordisk | 6 | $107 |
| Corcept Therapeutics | 5 | $82 |
| Pfizer | 5 | $73 |
| Lilly USA, LLC | 5 | $65 |
| Insulet Corporation | 1 | $65 |
| AstraZeneca | 5 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $52 |
| GSK | 3 | $44 |
| Bayer | 3 | $43 |
| Boston Scientific | 1 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Novartis | 2 | $37 |
| Medtronic | 2 | $34 |
| Exact Sciences | 2 | $33 |
| Welch Allyn | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Viatris Specialty LLC | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $15 |
| Amgen | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Axsome Therapeutics, Inc. | 1 | $9 |
How this compares
$1,729 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 32 | $38,708 |
| MounjaroTirzepatide | 14 | $27,986 |
| OzempicSemaglutide | 21 | $21,622 |
| EliquisApixaban | 13 | $9,210 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,391 |
| Insulin Lispro Junior KwikpenInsulin Lispro | 15 | $2,288 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,183 |
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 12 | $1,623 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $1,532 |
| Memantine Hcl | 16 | $1,190 |
| Omeprazole | 94 | $1,183 |
| Atorvastatin Calcium | 147 | $1,045 |
| Gabapentin | 53 | $941 |
| Levothyroxine Sodium | 69 | $781 |
| Metoprolol Succinate | 32 | $615 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $64 | $38,70832 claims |
| Lilly USA, LLCMounjaro | $65 | $27,98614 claims |
| Novo NordiskOzempic | $107 | $21,62221 claims |
| PfizerEliquis | $73 | $9,21013 claims |
| GSKShingrix | $44 | $2,39112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Twin Falls
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
- Paul BeckettBlackfoot$344K
- Elaine DavidsonMeridian$303K
- Kenneth CongerSandpoint$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.